IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Merck, DuPont, and More | GenomeWeb

Title: Method and Substances for Isolating miRNAs

Patent Number: 8,524,448

Filed: Aug. 29, 2012

Lead Inventor: Elliott Dawson, Bioventures

The invention, the patent's abstract states, comprises "a capture probe suitable for use with a method for isolating miRNAs."


Title: In Vivo Delivery of Double-stranded RNA to a Target Cell

Patent Number: 8,524,679

Filed: Nov. 6, 2007

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.

Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.

Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.

A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.